Stem-cell-like CD4+ T cells prey on MHC class II-negative tumors

Nature immunology

Joshua R Veatch, Joshua R Veatch, Joshua R Veatch, …, Stanley R Riddell, Joshua R Veatch, Stanley R Riddell

• DOI: 10.1038/s41590-023-01563-5
• PMID: 37460640